Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion. - sprookjes - yvandenbroek - TriplyDB

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

http://www.wikidata.org/entity/Q27853146

about

CIViC database Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Checkpoint inhibitors in hematological malignancies Translating RNA sequencing into clinical diagnostics: opportunities and challenges.Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.A three-signal model of T-cell lymphoma pathogenesis Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.Sézary syndrome: old enigmas, new targets.Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients.Precision oncology in the age of integrative genomics.Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.

P2860

7cb2ba8f6fd06c98ba3271a15b494656cc56b627

P248

Q27612411-FB8DDFD0-4A8C-4579-AE55-4782A931178A Q30239965-EA9569C6-2C86-46B5-8214-415368D97E54 Q33651495-943733B9-A52E-4031-A33B-65B55536C4AC Q34519034-7EA1EA9E-C259-4E1C-B58E-0A6F8A8DF36A Q36998864-8569C543-248D-4EAC-8AC4-7CEA5865089D Q37237891-E7778D7A-58F7-4E9B-B4F3-11193FD919F5 Q38593164-48CF78C0-9EB5-48FA-83FF-C3E142068C47 Q38677720-1483FF19-0D74-439B-A4A4-538B8DC69B2F Q38772711-AE422EA3-BD1F-4768-B2BA-82A2A883D7F8 Q38844903-8F664C5C-614C-47F8-99E7-EBA5C401DAFD Q38855013-586473BA-B0D0-47CF-831C-E12D43379BFD Q39023485-3C6E7A21-5D19-46E9-8E55-177A6FF40106 Q39055861-E5F41C52-419C-479C-A75C-99A142F59ECF Q42397480-40766831-9243-4E19-B5C7-75D527CF4993 Q47156033-9090BCC1-BCFA-4B74-9471-5FD4921C825D Q47567993-80BE8DDE-B5F9-4389-9DAB-3F3F07C25BC3 Q50105699-59F03F8B-37CD-4163-ABB4-2BD5838C0619 Q55106038-E7778E57-AEC9-4D49-AB66-96F0AE37A85C

P2860

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

http://www.wikidata.org/entity/Q27853146

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@ast

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@en

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@nl

type

label

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@ast

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@en

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@nl

altLabel

Personalized treatment of Sézary syndrome by targeting a novelCTLA4:CD28fusion

@en

prefLabel

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@ast

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@en

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

@nl

P1433

Q27853146-97AF64D9-466B-4916-85D4-F0532C6A91E1

P1476

Q27853146-E6342B8C-8C09-4DA2-9E82-525FD9AB85D2

P2093

Q27853146-0059C5B9-FB41-4439-B9C1-9F356EAF891F

Q27853146-01E1957C-08B5-408E-8191-6048F144D4BC

Q27853146-020B8DAF-134F-4540-8224-823BE4543867

Q27853146-31F993BF-B140-4A3C-99F4-A5777A60B3DC

Q27853146-3FF06663-DC75-4E38-9A47-281B392A04A4

Q27853146-420B2E75-9FB2-4797-9242-565D595673DC

Q27853146-42F58BC9-AD3E-4685-B66A-54A565DDB036

Q27853146-47D96F12-5F10-4D1B-AF94-461AD69F47F2

Q27853146-A83AF3C9-35D9-4897-BB44-C42591985AFE

Q27853146-B5E024CB-4A89-43CA-8167-3A64590B4EAC

P2860

Q27853146-11EF291E-F8D9-4801-84D5-46A384610B05

Q27853146-19B823BE-8EB8-4109-A31E-9973FE4EA2F7

Q27853146-2222C2AD-D384-413B-9A6D-1C36A1BB6277

Q27853146-2FED69A3-E9D3-473C-8344-9A1784F67A1B

Q27853146-34709592-854F-4D52-BAF4-CBB61ABBB92C

Q27853146-39C2C73B-5891-4DAC-8287-614DD05624C1

Q27853146-3C066FAC-14E6-4548-A14D-8A5BEC7938BB

Q27853146-46BAB01F-D026-401F-8A7A-1AC4028FAE40

Q27853146-597FF7EA-CFB1-4663-81C5-F1F33F64B672

Q27853146-6ACFEBC5-A0A6-4810-B414-B12681464C29

P304

Q27853146-BEC139BF-516C-4FBA-9479-AE3FA309E791

P31

Q27853146-88DDEAC9-4097-4E0A-A1DD-55918A4A1162

P356

Q27853146-1BF03702-750C-4196-9D41-E9E7573D3C58

P433

Q27853146-90A59ADC-52E1-404E-AE8C-BC2A541553CC

P478

Q27853146-AD42D23B-DE15-4456-B1EC-9E278F25FADD

P50

Q27853146-838F1CE9-A37D-4E9A-BC56-D68E95D901F0

P577

Q27853146-0DD01B30-2BD9-4A05-B1EE-D29CFB9DE861

P5875

Q27853146-74463921-4764-47E0-B3EA-440BA231BAA7

P698

Q27853146-0CD71D30-D9DF-4D26-BF1A-214404B94A00

P921

Q27853146-49D8490C-1770-4626-9BBF-1DAEFD88DE2E

P932

Q27853146-9DB2FB02-D56C-4B1E-9A0A-86359FB8B62D

P356

P1433

Molecular genetics & genomic medicine

P1476

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion

@en

P2093

Aleksandar Sekulic

http://www.w3.org/2001/XMLSchema#string

Christophe Legendre

http://www.w3.org/2001/XMLSchema#string

David W Craig

http://www.w3.org/2001/XMLSchema#string

Fernando R De Castro

http://www.w3.org/2001/XMLSchema#string

Jeffrey Trent

http://www.w3.org/2001/XMLSchema#string

John Carpten

http://www.w3.org/2001/XMLSchema#string

John J Gohmann

http://www.w3.org/2001/XMLSchema#string

Lori Cuyugan

http://www.w3.org/2001/XMLSchema#string

Mark R Pittelkow

http://www.w3.org/2001/XMLSchema#string

Semyon Kruglyak

http://www.w3.org/2001/XMLSchema#string

P2860

The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation

The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice

Wapl controls the dynamic association of cohesin with chromatin

BRAF mutations in hairy-cell leukemia

Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Accurate whole human genome sequencing using reversible terminator chemistry

Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins

TopHat: discovering splice junctions with RNA-Seq

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

P304

130-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MGG3.121

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268821006

http://www.w3.org/2001/XMLSchema#string

P698

25802883

http://www.w3.org/2001/XMLSchema#string

P921

P932

4367085

http://www.w3.org/2001/XMLSchema#string